Skip to Content

Terumo Group

News

Showing 1 to 9 of 26

Aug 3

Terumo’s PLAJEX Enters US Markets by Receiving GMP Certification from FDA to Manufacture Biosimilar Hulio

Aug 03, 2020
Jul 21

Terumo Statement Regarding Media Reports on Japanese Government's Subsidies Project

Jul 21, 2020
Jul 15

Terumo Acquires Quirem Medical to Enhance its Interventional Oncology Field

Jul 15, 2020
Apr 22

Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide

Apr 22, 2020
Apr 10

Terumo BCT and Marker Therapeutics Received the First Device FDA Emergency Use Authorization (EUA) to Treat Acute Respiratory Failure in COVID-19 Patients

Apr 10, 2020
Apr 3

Terumo Statement on COVID-19

Apr 03, 2020
Mar 17

Terumo Interventional Systems Statement Regarding Production (COVID-19)

Mar 17, 2020
Mar 12

Terumo Statement Regarding Production (COVID-19)

Mar 12, 2020
Feb 6

Terumo Announces Change of Executive Officers

Feb 06, 2020

Showing 1 to 9 of 26